Asahi Kasei Corporate Venture Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 5

Professionals

  • Investments
  • 74

  • Portfolio
  • 51

  • Exits
  • 17

Exits

Asahi Kasei Corporate Venture Capital General Information

Company Description

Founded in 2008, Asahi Kasei Corporate Venture Capital is the venture capital arm of Asahi Kasei based in Menlo Park, California. The firm prefers to invest in materials, homes, and healthcare sector.

Business Details

Year Founded
2008
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Corporate Office
  • 4600 Bohannon Drive
  • Suite 220
  • Menlo Park, CA 94025
  • United States
+1 (650)

Asahi Kasei Corporate Venture Capital Investments (74)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Glycomine 16-Apr-2025 Later Stage VC Drug Discovery Clinical Trials - Phase 2
Power to Hydrogen 19-Aug-2024 Energy Production Generating Revenue
Kins (Clinics/Outpatient Services) 16-Jul-2024 Clinics/Outpatient Services Generating Revenue
Syngoi 10-Jun-2024 Biotechnology Generating Revenue
WealthPark 14-May-2024 Business/Productivity Software Generating Revenue
Pulmocide 16-Apr-2024 Drug Discovery Clinical Trials - Phase 3
Cyto-Facto 31-Mar-2024 Other Commercial Services Generating Revenue
Noctrix Health 16-Jan-2024 Therapeutic Devices Clinical Trials - Phase 2
Topsound Technology 03-Jan-2024 Early Stage VC Machinery (B2B) Startup
Avation Medical 15-Dec-2023 Later Stage VC Therapeutic Devices Generating Revenue
You’re viewing 10 of 74 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Asahi Kasei Corporate Venture Capital Exits (17)

Company Name Exit Date Exit Type Exit Size
Curreio 09-Apr-2025 Bankruptcy: Liquidation
Tout Audio 27-Mar-2025
Humavox 01-Aug-2023
Mirexus 15-Feb-2023
Curonix 29-Oct-2022
Enerbee 02-Feb-2022
Rapid Micro Biosystems 15-Jul-2021
Respicardia 09-Apr-2021
Chrono Therapeutics 01-Feb-2021 Out of Business
Atox Bio 31-Dec-2019 Out of Business
You’re viewing 10 of 17 exits. Get the full list »

Asahi Kasei Corporate Venture Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Asahi Kasei Corporate Venture Capital Co-Investors (225)

Name With Exits Lead Partner Series Industry
Asahi Kasei Pharma Venture Capital 4 Series chart Industry bar
Asahi Kasei Series chart Industry bar
Asahi Kasei Medical Series chart Industry bar
Gaingels Series chart Industry bar
SMBC Venture Capital Series chart Industry bar
You’re viewing 5 of 225 co-investors. Get the full list »

Asahi Kasei Corporate Venture Capital FAQs

  • What is Asahi Kasei Corporate Venture Capital?

    Founded in 2008, Asahi Kasei Corporate Venture Capital is the venture capital arm of Asahi Kasei based in Menlo Park, California.

  • When was Asahi Kasei Corporate Venture Capital founded?

    Asahi Kasei Corporate Venture Capital was founded in 2008.

  • Where is Asahi Kasei Corporate Venture Capital headquartered?

    Asahi Kasei Corporate Venture Capital is headquartered in Menlo Park, CA.

  • How many investments has Asahi Kasei Corporate Venture Capital made?

    Asahi Kasei Corporate Venture Capital has made 74 investments.

  • What has Asahi Kasei Corporate Venture Capital invested in?

    Asahi Kasei Corporate Venture Capital has made numerous investments in companies like Glycomine, Power to Hydrogen, and Kins (Clinics/Outpatient Services) within the Drug Discovery, Energy Production, and Clinics/Outpatient Services industries.

  • What has Asahi Kasei Corporate Venture Capital invested in recently?

    Asahi Kasei Corporate Venture Capital's latest investment was on 16-Apr-2025 in Glycomine, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »